Lynn E. Heasley

11.2k citations
143 papers · 9.5k · 2 hit papers · h-index 52

Impact in

  • Oncology top 0.5%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Protein Kinase Regulation and GTPase Signaling
    • Melanoma and MAPK Pathways
    • Fibroblast Growth Factor Research
    • PI3K/AKT/mTOR signaling in cancer
    • Receptor Mechanisms and Signaling

Papers in

    • Protein Kinase Regulation and GTPase Signaling 30
    • Fibroblast Growth Factor Research 18
    • PI3K/AKT/mTOR signaling in cancer 17
    • Melanoma and MAPK Pathways 14
    • Cancer-related gene regulation 10
    • Receptor Mechanisms and Signaling 9
    • Cancer Immunotherapy and Biomarkers 11

Lynn E. Heasley

141 papers receiving 9.2k citations

Lynn E. Heasley's Hit Papers

Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer 2012 · 848 citations
8480+8+17Years since publication250500750

Peers

Lynn E. Heasley
Comparison fields: 5 of 126
  • Oncology 2.4k
  • Molecular Biology 5.8k
  • Cancer Research 1.1k
  • Immunology 1.2k
  • Pulmonary and Respiratory Medicine 1.6k
Replace Andrew S. Kraft with:
Andrew S. Kraft United States
Darren A.E. Cross United Kingdom
Vuk Stambolic Canada
Carol A. Lange United States
Alfonso Bellacosa United States
Markus Wartmann Switzerland
Jiping Zha United States
Christian Rommel United States
Amancio Carnero Spain
József Tı́már Hungary
Lynn E. Heasley relative to Andrew S. Kraft United States Andrew S. Kraft's profile →
Citations per field
00.5×1.5×2.3×
Andrew S. Kraft · 1×
Citations per year

Countries citing papers authored by Lynn E. Heasley

Since Specialization
Citations

This map shows the geographic impact of Lynn E. Heasley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn E. Heasley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn E. Heasley more than expected).

Fields of papers citing papers by Lynn E. Heasley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn E. Heasley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn E. Heasley. The network helps show where Lynn E. Heasley may publish in the future.

Co-authors

The 25 scholars most cited alongside Lynn E. Heasley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lynn E. Heasley Line = papers co-authored together Lynn E. Heasley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer
Hit paper breakdown →
2012848
2
Akt/Protein Kinase B Up-regulates Bcl-2 Expression through cAMP-response Element-binding Protein
Hit paper breakdown →
2000711
3 1993488
4 2018219
5 1992211
6 1989211
7 2013205
8 2008183
9 2012179
10 2001179
11 1995177
12
Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.
1999173
13 1995171
14 1997149
15 1997146
16 2005145
17 2017135
18 1992134
19 2014127
20 2002127

About Lynn E. Heasley

Lynn E. Heasley is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Cell Biology, having authored 143 papers that have together received 9.5k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (30 papers), Lung Cancer Treatments and Mutations (28 papers), Fibroblast Growth Factor Research (18 papers), PI3K/AKT/mTOR signaling in cancer (17 papers), Melanoma and MAPK Pathways (14 papers), Cancer Immunotherapy and Biomarkers (11 papers), Cancer-related gene regulation (10 papers) and Receptor Mechanisms and Signaling (9 papers). The work is most often cited by research in Oncology (2.4k citations), Molecular Biology (5.8k citations), Cancer Research (1.1k citations), Immunology (1.2k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Lynn E. Heasley has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Gary L. Johnson, Raphael A. Nemenoff, Raphael A. Nemenoff, Sunil Gupta, Robert C. Doebele, Lindsay A. Marek, Vicki Van Putten, Laura Butterfield, Wilbur A. Franklin and Subbiah Pugazhenthi. Their work appears in journals such as Journal of Biological Chemistry, Molecular Pharmacology, Cancer Research, Molecular and Cellular Biology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact